Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.
GLP-1 drugs like Ozempic and Wegovy revolutionized weight loss, but their high cost keeps them out of reach for most ...
In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...
An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use ...
"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...
And considering the rising popularity of Ozempic and other weight loss drugs, that is bound to catch folks’ attention. Toss ...
The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...
New research uncovers hidden risks and surprising benefits of weight loss drugs like Ozempic, reshaping how we see these ...
Add surgical tweaks to fix so-called "Ozempic face" to the list of top trending cosmetic procedures, as tallied by the ...
This week, the FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat: True or False: Two new trials ...
Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...
For an article about how weight-loss drugs affect marriage and intimacy, one health reporter worked with couples to “hold up a mirror to readers.” ...